Abstract
Orthoclone OKT3 has been used in the prophylaxis or treatment of acute graft-versus-host disease (GVHD). No previous report of Orthoclone OKT3 in the treatment of marrow allograft failure has been found. Here a case of chronic myelocytic leukemia is presented where the patient received unrelated bone marrow transplantation and developed late graft failure. After failing all other immunosuppressive agents, marrow allograft was successfully rescued by the use of Orthoclone OKT3.
| Original language | English |
|---|---|
| Pages (from-to) | 126-131 |
| Number of pages | 6 |
| Journal | Chinese Medical Journal (Taipei) |
| Volume | 59 |
| Issue number | 2 |
| Publication status | Published - 1997 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- bone marrow transplantation
- graft failure
- OKT3
ASJC Scopus subject areas
- General Medicine
Fingerprint
Dive into the research topics of 'Orthoclone OKT3 for graft failure after allogeneic bone marrow transplantation: A case report'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS